Parvovirus B19 (Human), IgG, IgM
Also known as: Human Parvovirus B19, IgG, IgM
Use
Differential diagnosis of acute or recent infection from past infection with human parvovirus associated with erythema infectiosum (fifth disease), aplastic crisis, and fetal infection
Special Instructions
Not provided.
Limitations
The test results are dependent on the quality of the specimen submitted. Hemolysis, lipemia, or gross bacterial contamination can lead to sample rejection. Cross-reaction with other antibodies or immunoglobulin classes, technical issues, or sample interference may also affect the results, potentially leading to false positives or negatives. The specific sensitivity and specificity of the test are not provided.
Methodology
Immunoassay (EIA)
Biomarkers
Human parvovirus B19, IgG
ProteinHuman parvovirus B19, IgM
Protein
LOINC Codes
- 34950-6 - B19V IgG+IgM Pnl Ser
- 5273-8 - B19V IgG Ser IA-aCnc
- 5274-6 - B19V IgM Ser IA-aCnc
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Maintain specimen at room temperature.
Causes for Rejection
Hemolysis; lipemia; gross bacterial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant